Prevalence and clinical outcome of mitral-valve prolapse.

PubWeight™: 5.01‹?› | Rank: Top 1%

🔗 View Article (PMID 10387935)

Published in N Engl J Med on July 01, 1999

Authors

L A Freed1, D Levy, R A Levine, M G Larson, J C Evans, D L Fuller, B Lehman, E J Benjamin

Author Affiliations

1: National Heart, Lung, and Blood Institute's Framingham Heart Study, Mass. 01702-6334, USA.

Associated clinical trials:

The Canadian Mitral Research Alliance (CAMRA) Trial CardioLink-2 (CAMRA) | NCT02552771

Articles citing this

(truncated to the top 100)

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med (2008) 4.33

Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 3.56

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Assessment of mitral regurgitation. Heart (2002) 1.81

Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol (2011) 1.73

Familial clustering of mitral valve prolapse in the community. Circulation (2014) 1.68

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging (2014) 1.47

Degenerative mitral valve disease-contemporary surgical approaches and repair techniques. Ann Cardiothorac Surg (2017) 1.39

Epidemiology of reflex syncope. Clin Auton Res (2004) 1.37

The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med (2009) 1.32

Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation. J Cell Physiol (2012) 1.13

A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet (2003) 1.10

Perspectives on mitral-valve prolapse. N Engl J Med (1999) 1.08

QT dispersion and diastolic functions in differential diagnosis of primary mitral valve prolapse and rheumatic mitral valve prolapse. Pediatr Cardiol (2007) 1.05

TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves. Cardiovasc Res (2013) 1.04

Mild expression of mitral valve prolapse in the Framingham offspring: expanding the phenotypic spectrum. J Am Soc Echocardiogr (2013) 1.02

Morphofunctional Abnormalities of Mitral Annulus and Arrhythmic Mitral Valve Prolapse. Circ Cardiovasc Imaging (2016) 1.01

Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation (2014) 1.00

Early surgical intervention or watchful waiting for the management of asymptomatic mitral regurgitation: a systematic review and meta-analysis. Ann Cardiothorac Surg (2015) 1.00

Congenital heart malformations induced by hemodynamic altering surgical interventions. Front Physiol (2014) 0.97

[Aortic stenosis]. Clin Res Cardiol (2006) 0.92

Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies. Int J Cardiovasc Imaging (2011) 0.92

Marfan syndrome and mitral valve prolapse. J Clin Invest (2004) 0.92

P-wave dispersion and heart rate variability in children with mitral valve prolapse. Pediatr Cardiol (2011) 0.91

Genetic association analyses highlight biological pathways underlying mitral valve prolapse. Nat Genet (2015) 0.91

Degenerative mitral valve disease with emphasis on mitral valve prolapse. Heart (2002) 0.89

Mutations in DCHS1 cause mitral valve prolapse. Nature (2015) 0.89

Measurement of mitral leaflet and annular geometry and stress after repair of posterior leaflet prolapse: virtual repair using a patient-specific finite element simulation. Ann Thorac Surg (2014) 0.89

The unsaddled annulus: biomechanical culprit in mitral valve prolapse? Circulation (2013) 0.88

Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease. Circ Cardiovasc Genet (2015) 0.88

Antithrombotic medication for cardioembolic stroke prevention. Stroke Res Treat (2011) 0.87

A familial syndrome of pulmonary nontuberculous mycobacteria infections. Am J Respir Crit Care Med (2013) 0.86

Aberrant right ventricular branch of right coronary artery with mitral valve prolapse. Exp Clin Cardiol (2004) 0.86

Evolution of Mitral Valve Prolapse: Insights From the Framingham Heart Study. Circulation (2016) 0.86

Sonographic markers for early diagnosis of fetal malformations. World J Radiol (2013) 0.86

Aortic Disease Presentation and Outcome Associated With ACTA2 Mutations. Circ Cardiovasc Genet (2015) 0.85

Sex differences in morphology and outcomes of mitral valve prolapse. Ann Intern Med (2008) 0.85

The migraine association with cardiac anomalies, cardiovascular disease, and stroke. Neurol Clin (2009) 0.84

Preoperative scallop-by-scallop assessment of mitral prolapse using 2D-transthoracic echocardiography. Cardiovasc Ultrasound (2010) 0.84

Mitral valve disease-morphology and mechanisms. Nat Rev Cardiol (2015) 0.84

Basic mechanisms of mitral regurgitation. Can J Cardiol (2014) 0.83

Assessment of functional anatomy of the mitral valve in patients with mitral regurgitation with cine magnetic resonance imaging: comparison with transesophageal echocardiography and surgical results. Eur Radiol (2007) 0.83

Feasibility of myxomatous mitral valve repair using direct leaflet and chordal radiofrequency ablation. J Interv Cardiol (2008) 0.82

Mitral valve mechanics following posterior leaflet patch augmentation. J Heart Valve Dis (2013) 0.82

Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly. Int J Inflam (2011) 0.81

Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome. PLoS One (2012) 0.80

Translational research on the mitral valve: from developmental mechanisms to new therapies. J Cardiovasc Transl Res (2011) 0.80

Left ventricular function and C-reactive protein levels in acute myocardial infarction. Am J Cardiol (2010) 0.80

Auscultation of the Chest and Abdomen by Athletic Trainers. J Athl Train (2001) 0.80

Percutaneous and surgical treatment of mitral valve regurgitation. Dtsch Arztebl Int (2011) 0.79

The main pulmonary artery in adults: a controlled multicenter study with assessment of echocardiographic reference values, and the frequency of dilatation and aneurysm in Marfan syndrome. Orphanet J Rare Dis (2014) 0.79

Evaluation of left ventricular systolic function in young adults with mitral valve prolapse. Exp Clin Cardiol (2012) 0.79

Enlarged Dural Sac in Idiopathic Bronchiectasis Implicates Heritable Connective Tissue Gene Variants. Ann Am Thorac Soc (2016) 0.79

Anatomy of the mitral valve apparatus: role of 2D and 3D echocardiography. Cardiol Clin (2013) 0.78

Pathophysiology of valvular heart disease. Exp Ther Med (2016) 0.78

In Vitro System for Measuring Chordal Force Changes Following Mitral Valve Patch Repair. Cardiovasc Eng Technol (2012) 0.78

Mitral valve prolapse and sudden cardiac arrest in the community. Heart Rhythm (2015) 0.78

Observational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations. PLoS One (2013) 0.78

Electrocardiographic changes in mitral valve prolapse syndrome. J Cardiovasc Thorac Res (2014) 0.77

Chronic q Fever detection in the Netherlands. Clin Infect Dis (2011) 0.77

Adult women with mitral valve prolapse are more flexible. Br J Sports Med (2005) 0.77

Genetics of valvular heart disease. Curr Cardiol Rep (2014) 0.77

Reduction in malignant ventricular arrhythmia and appropriate shocks following surgical correction of bileaflet mitral valve prolapse. J Interv Card Electrophysiol (2016) 0.77

Does the association between mitral valve prolapse and panic disorder really exist? Prim Care Companion J Clin Psychiatry (2008) 0.76

Prevalence of mitral valve prolapse and associated valvular regurgitations in healthy teenagers undergoing screening echocardiography. Exp Clin Cardiol (2010) 0.76

Cardiac Causes of Stroke. Curr Treat Options Neurol (2000) 0.76

Mitral-valve prolapse. N Engl J Med (1999) 0.75

Coexistence of abnormal systolic motion of mitral valve in a consecutive group of 324 adult Tetralogy of Fallot patients assessed with echocardiography. Open Heart (2016) 0.75

Reverse Δ-wave as a possible sign in electrocardiography to diagnose mitral valve prolapse. BMC Res Notes (2011) 0.75

Mitral valve surgery: Does it really decrease ventricular arrhythmia in patients with mitral valve prolapse? Indian Pacing Electrophysiol J (2016) 0.75

Finite Element Modeling of Mitral Valve Repair. J Biomech Eng (2016) 0.75

Mitral-valve prolapse. N Engl J Med (1999) 0.75

Left Ventricular Ejection Index as a Marker of Early Myocardial Dysfunction in Primary Mitral Regurgitation: Novel or Old in Disguise? Circ Cardiovasc Imaging (2015) 0.75

Response to Letter Regarding Article, "Familial Clustering of Mitral Valve Prolapse in the Community". Circulation (2015) 0.75

Cost of vitamin K antagonist anticoagulant treatment in patients with metallic prosthetic valve in mitral position. SAGE Open Med (2016) 0.75

Stabilized Collagen and Elastin-Based Scaffolds for Mitral Valve Tissue Engineering. Tissue Eng Part A (2016) 0.75

Infectious agents is a risk factor for myxomatous mitral valve degeneration: A case control study. BMC Infect Dis (2017) 0.75

Predictors of Exercise-Induced Pulmonary Hypertension in Patients with Asymptomatic Degenerative Mitral Regurgitation: Mechanistic Insights from 2D Speckle-Tracking Echocardiography. Sci Rep (2017) 0.75

Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia. Heart (2016) 0.75

Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse. J Toxicol Pathol (2016) 0.75

The prevalence of hypomagnesaemia in pediatric patients with mitral valve prolapse syndrome and the effect of mg therapy. Int Cardiovasc Res J (2012) 0.75

Comparison of the accuracy of cardiac computed tomography angiography and transthoracic echocardiography in the diagnosis of mitral valve prolapse. Adv Biomed Res (2015) 0.75

Classification of prolapsed mitral valve versus healthy heart from phonocardiograms by multifractal analysis. Comput Math Methods Med (2013) 0.75

Sudden cardiac arrest and coexisting mitral valve prolapse: a case report and literature review. Echo Res Pract (2016) 0.75

Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. Oxid Med Cell Longev (2017) 0.75

Neochord placement versus triangular resection in mitral valve repair: A finite element model. J Surg Res (2016) 0.75

Nonacute coronary syndrome anginal chest pain. Med Clin North Am (2010) 0.75

Echocardiographic assessment of mitral valve regurgitation, pattern and prevalence, expanding clinical awareness through an institutional survey with the perspective of a quality improvement project. Clin Med Insights Cardiol (2014) 0.75

Clinical decision making-a functional medicine perspective. Glob Adv Health Med (2012) 0.75

Incidence and Predictors of Infective Endocarditis in Mitral Valve Prolapse: A Population-Based Study. Mayo Clin Proc (2016) 0.75

Minimally invasive mitral valve repair through right minithoracotomy in the setting of degenerative mitral regurgitation: early outcomes and long-term follow-up. Ann Cardiothorac Surg (2015) 0.75

Diastolic Function Evaluations by Tissue Doppler Imaging in Patients With Mitral Valve Prolapse. Cardiol Res (2013) 0.75

Mitral valve prolapse: where is the missing link? J Thorac Dis (2016) 0.75

[Valvular heart disease in hospitals in Lome (Togo)]. Pan Afr Med J (2015) 0.75

Piezogenic Pedal Papules with Mitral Valve Prolapse. Indian J Dermatol (2016) 0.75

Biomechanical evaluation of the pathophysiologic developmental mechanisms of mitral valve prolapse: effect of valvular morphologic alteration. Med Biol Eng Comput (2015) 0.75

Standard transthoracic echocardiography and transesophageal echocardiography views of mitral pathology that every surgeon should know. Ann Cardiothorac Surg (2015) 0.75

Articles by these authors

Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63

Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54

Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24

Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84

The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01

The progression from hypertension to congestive heart failure. JAMA (1996) 7.56

Lifetime risk of developing coronary heart disease. Lancet (1999) 7.54

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76

Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72

Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00

Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med (1998) 5.63

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43

Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation (1999) 5.04

Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74

Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation (2000) 4.63

Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61

Comparisons of five health status instruments for orthopedic evaluation. Med Care (1990) 4.57

Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation (1994) 4.52

Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol (1998) 4.44

The somatic replication of DNA methylation. Cell (1981) 4.42

Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11

Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum (1997) 4.08

Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05

Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum (1989) 4.02

The carpal tunnel syndrome: diagnostic utility of the history and physical examination findings. Ann Intern Med (1990) 4.02

Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med (1997) 3.96

The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1995) 3.93

Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89

Cancer: improving early detection and prevention. A community practice randomised trial. BMJ (1992) 3.76

An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) Am J Cardiol (1992) 3.66

Effects of ambient air pollution on nonelderly asthma hospital admissions in Seattle, Washington, 1987-1994. Epidemiology (1999) 3.57

Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44

Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation (1994) 3.44

A controlled trial of an educational program to prevent low back injuries. N Engl J Med (1997) 3.33

The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19

Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12

Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol (1995) 3.08

Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95

Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. Proc Natl Acad Sci U S A (1986) 2.92

Comparative measurement sensitivity of short and longer health status instruments. Med Care (1992) 2.89

American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87

Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension (1998) 2.86

Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum (1985) 2.85

Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81

Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81

Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med (1992) 2.77

Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension (2000) 2.76

C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis (2000) 2.71

Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58

Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol (2001) 2.57

Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation (2001) 2.54

Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53